CGCharlotta Granström

Charlotta Granström

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Charlotta Granström has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Kari Hemminki

    Biomedical Center, Faculty of Medicine Charles University Pilsen Pilsen Czech Republic

    2 shared publications
  • J Sundquist

    Department of Neurobiology, Caring Sciences and Society, Center for Family and Community Medicine, Karolinska Institute, Alfred Nobels allé 12 Huddinge 141 83, Sweden

    1 shared publication
  • Jan Sundquist

    Karolinska Institute

    1 shared publication
  • K Hemminki

    Department of Neurobiology, Caring Sciences and Society, Center for Family and Community Medicine, Karolinska Institute, Alfred Nobels allé 12 Huddinge 141 83, Sweden

    1 shared publication
  • Kari Hemminki

    Karolinska Institute

    1 shared publication

Latest Publications

  • Open Access

    Population attributable fractions for ovarian cancer in Swedish women by morphological type

    by C Granström, J Sundquist, K Hemminki

    Using the Swedish Family-Cancer Database, among a total of 1 030 806 women followed from 1993 through 2004, invasive and borderline epithelial ovarian cancer was identified in 3306 and 822 women respectively, with data on family history, reproductive variables, residential region and socioeconomic status. Relative risks and population-attributable fractions (PAFs) were estimated by Poisson regression. The overall PAFs of invasive epithelial ovarian cancer for family history and for reproductive factors were 2.6 and 22.3%, respectively, for serous/seropapillary cystadenocarcinoma (3.0 and 19.1%), endometrioid carcinoma (2.6 and 26.6%), mucinous cystadenocarcinoma (0.5 and 23.9%) and clear-cell carcinoma (2.6 and 73.9%). The corresponding PAFs of borderline tumours due to family history were lower, but higher due to reproductive factors. Family history, low parity and young age at first birth were associated with elevated risks. The risks for women with a family history were among the highest, but these women accounted for the smallest proportion of the cases, giving the lowest PAFs.


  • Population attributable risks for breast cancer in Swedish women by morphological type

    by Charlotta Granström, Jan Sundquist, Kari Hemminki

    The purpose of this population-based cohort study is to describe the etiology of invasive and in situ breast cancer, using the Swedish Family-Cancer Database. A total of 1,028,455 women, aged 40–61 years, were followed from 1993 through 2004. Invasive and in situ breast cancer was identified in 27,243 and 3,496 women, respectively, with data on family history, reproductive variables, residential region and socioeconomic status. Relative risks (RRs) and population attributable fractions (PAFs) were estimated by Poisson regression. The overall PAF of invasive breast cancer was 5.3% for family history and 17.9% for reproductive factors. Morphology-specific PAFs were calculated for ductal (family history: 5.2%, reproductive factors: 16.6%), lobular (family history: 6.2%, reproductive factors: 19.9%) and comedo types (family history: 5.2%, reproductive factors: 25.9%). The corresponding PAFs of in situ tumors were higher due to family history and reproductive factors. Family history, late age at first birth and high socioeconomic status were associated with elevated risks in all morphologies, whereas low parity did not have an impact on the invasive and in situ lobular and comedo tumors. The risks for women with a family history were the highest, but these women accounted for the smallest proportion of the cases, thus resulting in the lowest PAFs.


  • Familial breast carcinoma risks by morphology

    by Kari Hemminki, Charlotta Granström

    Familial risks in patients with breast carcinoma have not been assessed by morphologic types of medically verified cancers. Reliable data on familial risks would help to establish prevention programs and guide clinical decisions. We used the nationwide Swedish Family-Cancer Database to calculate standardized incidence ratios (SIRs) and 95% confidence intervals (CIs) for invasive and in situ breast carcinomas in women with mothers and sisters. This database has information on 10.2 million individuals and on more than 13,000 morphology-specific breast carcinomas. SIRs for all invasive breast carcinomas were 1.82 (95% CI 1.71-1.93) for breast carcinoma in the mother and 1.89 (1.70-2.01) for breast carcinoma in a sister. The respective risks were 1.81 and 1.85 for a mother and sisters with ductal breast carcinoma. The SIRs were equally for lobular, tubuloductal, comedo, and mucinous breast carcinomas. However, the SIRs for lobular carcinoma were lower than those for the ductal type, whereas the opposite trend was noted for the comedo and mucinous type; none of the differences were significant. The risks for all morphologic types were highest when both a mother and a sister were affected, SIR 3.19 (2.36-4.22). The risks for in situ breast carcinomas were 2.09 (1.78-2.44) for an affected mother, 2.24 (1.88-2.85) for an affected sister, and 5.23 (2.59-9.39) when both a mother and a sister were affected. The data suggest that the familial risk of breast carcinoma is independent of the morphologic type. The higher risks in in situ cancer may be due to medical surveillance. The risks were identical from a mother or sister proband, suggesting that recessive effects are unlikely as a heritable cause of breast carcinoma.